Following this study period, the patients were randomized into two arms, either continuing tirzepatide therapy or continuing with placebo (85)
No, there are currently no GLP-1 patches licensed by the MHRA or approved by NICE for use in the United Kingdom
Effects of GLP-1RAs appear to be mediated through the modulation of reward pathways, stress regulation, and cognitive function in the CNS, as well as a host of functions in the periphery
The news around GLP-1s tends to read like a highlight reel
This study, published in a large Massachusetts database, highlights the need for eye care professionals to be vigilant when treating patients on GLP-1 medications
Patient assistance programs for eligible patients If your household income falls below certain thresholds, you may qualify for free medication through a Patient Assistance Program (PAP)